Royalty Report: Medical, Device, Ophthalmological – Collection: 27930

$100.00

Curated Royalty Rate Report
Created On: 2020-07-15, Record Count: 3

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Created On: 2020-07-15
Record Count: 3

Primary Industries

  • Medical
  • Device
  • Ophthalmological
  • Surgical

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 27930

License Grant
In a related party transaction, we sold Solx to Licensee, a company wholly-owned by Doug P. Adams who, until the closing of the sale, was an executive officer of Licensor.
License Property
Included in the sale were the Solx 790 Laser, a flashlamp-excited, solid-state laser that emits near-infrared light (790 nm) in pulses lasting five to10 microseconds, and the Solx Gold Shunt, biocompatible, 24-karat gold implant that uses the eye's natural pressure differential (uveal scleral outflow) to reduce Intraocular Pressure without a bleb.

IPSCIO Record ID: 5827

License Grant
The Company entered into a Patent License Agreement to obtain the exclusive license to U.S. Patent No.08/781,504 and No. 6,059,772.
License Property
DeepLight®790 is a medical device system for the treatment of glaucoma.

IPSCIO Record ID: 1975

License Grant
The Company licensed it intellectual laser properties; patented ultrafast laser systems for the treatment of a broad range of eye disorders.
License Property
Licensor’s solid-state pico-second (one trillionth of a second) Nd: YLF (Neodymium:Yitrium-Lithium-Fluoride) laser systems are designed to be more precise than lasers systems utilizing currently available technologies.
Field of Use
The rights granted apply to the healthcare market specializing in ophthalmic medical devices.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.